Skip to content

Article: Human CD157 Enzyme Regulates NAD+ Precursors to Support Metabolism: Preclinical Findings

Human CD157 Enzyme Regulates NAD+ Precursors to Support Metabolism: Preclinical Findings


Synopsis

Human CD157 (hCD157) is an enzyme that helps regulate cell metabolism and immune function and may be linked to neurodegenerative and metabolic diseases. Researchers found that hCD157 breaks down two vitamin-like molecules—nicotinamide riboside (NR) and nicotinic acid riboside (NAR)—which are precursors to NAD+, a key compound for energy production and cell repair. The enzyme releases nicotinamide or nicotinic acid from these molecules, and this activity can be blocked by a specific inhibitor. Detailed studies showed that hCD157 binds NR and slowly processes it through multiple steps, suggesting it may control the availability of NAD+ precursors or act as a sensor for these molecules. Comparing hCD157 to a related enzyme, hCD38, revealed that small structural differences explain why hCD157 prefers certain substrates. Overall, the study provides new insight into how hCD157 could affect metabolism, aging, and immune system regulation.

Journal

Archives of Biochemistry and Biophysics

Read more

Mitochondrial Disease

Nicotinamide Riboside Improved Endurance in Mitochondrial Disease: Preclinical Findings

Synopsis Mitochondrial disorders are rare but serious diseases caused by defects in the cell’s energy-producing machinery, known as the mitochondrial respiratory chain. These conditions often lead...

Read more
Metabolic Health

A High-Fat Diet and Increasing NAD+ Rescues Premature Aging in Cockayne Syndrome: Preclinical Findings

Synopsis Cockayne syndrome (CS) is a rare genetic disorder that causes early aging and progressive brain degeneration due to problems in DNA repair genes (CSA or CSB). In mice with the CSB mutatio...

Read more